Synairgen plc (LON:SNG – Get Free Report)’s share price dropped 18.1% during mid-day trading on Thursday . The company traded as low as GBX 2.21 ($0.03) and last traded at GBX 2.21 ($0.03). Approximately 319,444 shares were traded during trading, a decline of 7% from the average daily volume of 342,987 shares. The stock had previously closed at GBX 2.70 ($0.03).
Synairgen Stock Performance
The company has a quick ratio of 6.35, a current ratio of 6.77 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of £5.34 million, a P/E ratio of -88.33 and a beta of -2.23. The company’s 50 day moving average is GBX 4.11 and its 200-day moving average is GBX 4.20.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Recommended Stories
- Five stocks we like better than Synairgen
- Trading Stocks: RSI and Why it’s Useful
- Work and Play: Investing in the Rise of Bleisure Travel
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Differences Between Momentum Investing and Long Term Investing
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
